Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,624 | 63,336 | 39,394 | 0 | N/A |
| Marketable Securities | 219,359 | 37,929 | 11,546 | 0 | N/A |
| TOTAL | $292,826 | $106,474 | $51,098 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,016 | 227 | N/A | 0 | N/A |
| Other Non-Current Assets | 3,427 | 311 | 0 | 0 | 0 |
| TOTAL | $5,443 | $538 | $N/A | $N/A | $N/A |
| Total Assets | $298,269 | $107,012 | $51,098 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,140 | 1,405 | 1,801 | 0 | 0 |
| Accrued Expenses | 15,462 | 3,654 | 872 | 0 | N/A |
| TOTAL | $22,602 | $5,237 | $2,673 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,046 | 166,804 | 72,412 | 0 | 0 |
| TOTAL | $5,046 | $166,804 | $72,412 | $N/A | $N/A |
| Total Liabilities | $27,648 | $172,041 | $75,085 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,085 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | N/A | N/A | 0 | N/A |
| Retained earnings | -201,950 | -66,272 | -24,276 | 0 | N/A |
| Other shareholders' equity | -2 | -1 | 0 | 0 | 0 |
| TOTAL | $270,621 | $-65,029 | $-23,987 | $0 | $N/A |
| Total Liabilities And Equity | $298,269 | $107,012 | $51,098 | $0 | $0 |